Trask Adam Roland’s Novo Nordisk NVO Stock Holding History

Trask Adam Roland’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.35K	Buy	+200	New	+$9.48K	0.01%	173

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Trask Adam Roland's NVO Position: Q1 2026 in Review

Trask Adam Roland opened a new position in Novo Nordisk (NVO) in Q1 2026: 200 shares worth $7.35K. The stake represents 0.01% of the portfolio and ranks #173 among its holdings.

1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Trask Adam Roland held 200 shares of Novo Nordisk worth $7.35K as of Q1 2026.
Novo Nordisk was a new Trask Adam Roland position in Q1 2026.
Novo Nordisk made up 0.01% of Trask Adam Roland's portfolio in Q1 2026, its #173 holding.
1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Trask Adam Roland's 13F filing for Q1 2026, filed 15 May 2026.